Advantages of Autologous Blood Transfusion in Off-Pump Coronary Artery Bypass
DOI:
https://doi.org/10.1532/HSF98.20081115Abstract
In this randomized controlled study, we investigated the effects of autologous Hemobag blood transfusion (AHBT) and allogenic blood transfusion (ABT) in off-pump coronary artery bypass (OPCAB) surgery.
Methods: Sixty patients who underwent surgery between February 2008 and August 2008 were randomized into 2 groups. The AHBT group (n = 30) consisted of patients who received autologous Hemobag blood transfusion, and the ABT group (n = 30) consisted of patients who received allogenic blood transfusion. All patients underwent OPCAB via sternotomy. The time to extubation, chest tube drainage volume, postoperative white blood cell counts, amount of blood transfusion, sedimentation rate, C-reactive protein concentration, postoperative temperature, and the presence of atelectasis were recorded in the intensive care unit.
Results: Intraoperative bleeding and fluid resuscitation were similar in the 2 groups (P > .05); however, there were significant decreases in postoperative blood loss, extubation period, postoperative white cell counts, sedimentation rate, incidence of atelectasis, C-reactive protein, and fever in the AHBT group compared with the ABT group (P < .05). The rate of atrial fibrillation in the AHBT group tended to be lower than in the ABT group.
Conclusion: Autologous blood transfusion in OPCAB may be beneficial in certain cardiac surgery patients; however, these beneficial effects require further study to be proved.
References
Allain J-P, Akehurst RL, Hunter JM. 2002. Autologous transfusion, 3 years on: What is new? What has happened? Transfusion 39:910-1.nAronson D, Boulos M, Suleiman A, et al. 2007. Relation of C-reactive protein and new-onset atrial fibrillation in patients with acute myocardial infarction. Am J Cardiol 100:753-7.nAscione R, Williams S, Lloyd CT, Sundaramoorthi T, Pitsis AA, Angelini GD. 2001. Reduced postoperative blood loss and transfusion requirement after beating-heart coronary operations: a prospective randomized study. J Thorac Cardiovasc Surg 121:689-96.nBanbury MK, Brizzio ME, Rajeswaran J, Lytle BW, Blackstone EH. 2006. Transfusion increases the risk of postoperative infection after cardiovascular surgery. J Am Coll Surg 202:131-8.nBryson GL, Laupacis A, Wells GA. 1998. Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A meta-analysis. The International Study of Perioperative Transfusion. Anesth Analg 86:9-15.nCasati V, Benussi S, Sandrelli L, Grasso MA, Spagnolo S. 2004. Intraoperative moderate acute normovolemic haemodilution associated with a comprehensive blood-sparing protocol in off-pump coronary surgery. Anesth Analg 98:1217-23.nFeng ZZ, Shi J, Zhao XW, Xu ZF. 2009. Meta-analysis of on-pump and off-pump coronary arterial revascularization. Ann Thorac Surg 87:757-65.nGoodnough LT. 1993. Blood conservation and blood transfusion practices: flip sides of the same coin. Ann Thorac Surg 56:3-4.nGwozdziewicz M, Olsak P, Lonsky V, Elfmark M. 2008. The choice of on- or off-pump coronary bypass grafting: a surgeon's dilemma. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 152:289-92.nJamnicki M, Kocian R, van der Linden P, Zaugg M, Spahn DR. 2003. Acute normovolemic haemodilution: physiology, limitations, and clinical use. J Cardiothorac Vasc Anesth 17:747-54.nKaramanoukian HL, Panos AL, Bergsland J, Salerno TA. 2000. Perspectives of a cardiac surgery resident in-training on off-pump coronary bypass operation. Ann Thorac Surg 69:42-5.nMack MJ, Brown PP, Kugelmass AD, et al. 2004. Current status and outcomes of coronary revascularization 1999 to 2002: 148,396 surgical and percutaneous procedures. Ann Thorac Surg 77:761-6.nMatot I, Scheinin O, Jurim O, Eid A. 2002. Effectiveness of acute normovolemic haemodilution to minimize allogeneic blood transfusion in major liver resections. Anesthesiology 97:794-800.nPopovsky MA, Devine PA, Taswell HF. 1985. Intraoperative autologous transfusion. Mayo Clin Proc 60:125-34.nPuskas JD, Thourani VH, Marshall JJ, et al. 2001. Clinical outcomes, angiographic patency, and resource utilization in 200 consecutive off-pump coronary bypass patients. Ann Thorac Surg 71:1477-84.nRastan AJ, Eckenstein JI, Hentschel B, et al. 2006. Emergency coronary artery bypass graft surgery for acute coronary syndrome: beating heart versus conventional cardioplegic cardiac arrest strategies. Circulation 114(suppl):I477-85.nRittoo D, Gosling P, Simms MH, Smith SR, Vohra RK. 2005. The effects of hydroxyethyl starch compared with gelofusine on activated endothelium and the systemic inflammatory response following aortic aneurysm repair. Eur J Vasc Endovasc Surg 30:520-4.nSamolyk KA, Beckmann SR, Bissinger RC. 2005. A new practical technique to reduce allogeneic blood exposure and hospital costs while preserving clotting factors after cardiopulmonary bypass: the Hemobag. Perfusion 20:343-9.nScott H, Seifert FC, Grimson R. 2008. Blood transfusion is associated with increased resource utilisation, morbidity and mortality in cardiac surgery. Ann Card Anaesth 11:15-9.nSegal JB, Blasco-Colmenares E, Norris EJ, Guallar E. 2004. Preoperative acute normovolemic hemodilution: a meta-analysis. Transfusion 44:632-44.nStaton GW, Williams WH, Mahoney EM, et al. 2005. Pulmonary outcomes of off-pump vs on-pump coronary artery bypass surgery in a randomized trial. Chest 127:892-901.nStehling L, Zauder HL. 1991. Acute normovolemic haemodilution. Transfusion 31:857-68.nTreib J, Haass A, Pindur G, et al. 1995. HES 200/0.5 is not HES 200/0.5. Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kinetics. Thromb Haemost 74:1452-6.nTreib J, Haass A, Pindur G, Treib W, Wenzel E, Schimrigk K. 1996. Influence of intravascular molecular weight of hydroxyethyl starch on platelets. Eur J Haematol 56:168-72.n
